These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 1885258

  • 1. Levels of acylation stimulating protein in obese women before and after moderate weight loss.
    Sniderman AD, Cianflone KM, Eckel RH.
    Int J Obes; 1991 May; 15(5):333-6. PubMed ID: 1885258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
    Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural A, Ozdemir IC.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes.
    Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K.
    Int J Obes (Lond); 2006 Mar; 30(3):439-46. PubMed ID: 16302015
    [Abstract] [Full Text] [Related]

  • 6. Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians.
    Weyer C, Pratley RE.
    Obes Res; 1999 Sep; 7(5):444-52. PubMed ID: 10509601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma acylation-stimulating protein in coronary artery disease.
    Cianflone K, Zhang XJ, Genest J, Sniderman A.
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1239-44. PubMed ID: 9261252
    [Abstract] [Full Text] [Related]

  • 9. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children.
    Cianflone K, Lu H, Smith J, Yu W, Wang H.
    Clin Endocrinol (Oxf); 2005 May; 62(5):567-72. PubMed ID: 15853826
    [Abstract] [Full Text] [Related]

  • 10. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O.
    Ann Nutr Metab; 2007 May; 51(2):134-8. PubMed ID: 17536190
    [Abstract] [Full Text] [Related]

  • 11. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women.
    Ryan AS, Nicklas BJ, Berman DM, Elahi D.
    Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1066-71. PubMed ID: 12917712
    [Abstract] [Full Text] [Related]

  • 12. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.
    Cianflone K, Maslowska M, Sniderman AD.
    Semin Cell Dev Biol; 1999 Feb; 10(1):31-41. PubMed ID: 10355026
    [Abstract] [Full Text] [Related]

  • 13. The effect of ASP on the adipocyte of the morbidly obese.
    Walsh MJ, Sniderman AD, Cianflone K, Vu H, Rodriguez MA, Forse RA.
    J Surg Res; 1989 May; 46(5):470-3. PubMed ID: 2654479
    [Abstract] [Full Text] [Related]

  • 14. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.
    Paglialunga S, Fisette A, Yan Y, Deshaies Y, Brouillette JF, Pekna M, Cianflone K.
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E521-9. PubMed ID: 18160458
    [Abstract] [Full Text] [Related]

  • 15. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M, Juhan-Vague I.
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [Abstract] [Full Text] [Related]

  • 16. Metabolic response of Acylation Stimulating Protein to an oral fat load.
    Cianflone K, Vu H, Walsh M, Baldo A, Sniderman A.
    J Lipid Res; 1989 Nov; 30(11):1727-33. PubMed ID: 2693569
    [Abstract] [Full Text] [Related]

  • 17. Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.
    Oktenli C, Ozgurtas T, Dede M, Sanisoglu YS, Yenen MC, Yesilova Z, Kenar L, Kurt YG, Baser I, Smith J, Cianflone K.
    Gynecol Endocrinol; 2007 Dec; 23(12):710-5. PubMed ID: 18075846
    [Abstract] [Full Text] [Related]

  • 18. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T, Abbasi F, Lamendola C, Kim HS, Reaven GM.
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [Abstract] [Full Text] [Related]

  • 19. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.
    Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P.
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1034-9. PubMed ID: 11397716
    [Abstract] [Full Text] [Related]

  • 20. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R.
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.